CEO Tim Dyer Addex is getting a CHF 5 million ... agreed to an $8.7 billion takeover by AbbVie – as well as Sage Therapeutics/Biogen, which got FDA approval last year for GABAA receptor PAM ...
Sage Therapeutics (NASDAQ:SAGE) stock drops as Bank of America issues an Underperform rating citing an end to Biogen's (BIIB) ...
BofA resumed coverage of Sage Therapeutics (SAGE) with an Underperform rating and $5 price target. The impact of Biogen’s (BIIB) unsolicited ...
Philadelphia, Pennsylvania-- (Newsfile Corp. - March 8, 2025) - Grabar Law Office is investigating claims on behalf of Sage Therapeutics, Inc. (NASDAQ: SAGE) shareholders. The investigation concerns ...
Zacks Investment Research on MSN1d
Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?A month has gone by since the last earnings report for Sage Therapeutics, Inc. (SAGE). Shares have added about 7.4% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
Sage Therapeutics has left its view of Biogen's recent takeover bid in little doubt – it has just filed a lawsuit seeking to block the deal. Specific details of the lawsuit are not yet available ...
Yes, you read that right. The BlackRock CEO fat cat the political right had loved to hate has suddenly become the darling of the MAGA movement following his $22.8 billion purchase of ports from ...
Former Riggi mansion in Saratoga back on the market for $24.9M © 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback